Clinical Trials Directory

Trials / Conditions / COVID-19 Prevention

COVID-19 Prevention

11 registered clinical trials studyying COVID-19 Prevention — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.
NCT07445971
ModeX Therapeutics, An OPKO Health CompanyPhase 1
UnknownSafety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray
NCT05437029
Kenneth PalmerPhase 1
CompletedPREVENT-COVID-19: A Q-Griffithsin Intranasal Spray
NCT05122260
Kenneth PalmerPhase 1
CompletedA Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults
NCT05091307
Janssen Vaccines & Prevention B.V.Phase 3
CompletedA Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19)
NCT04765384
Janssen Vaccines & Prevention B.V.Phase 2
CompletedA Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults
NCT04908722
Janssen Vaccines & Prevention B.V.Phase 3
UnknownHydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19
NCT04858633
Post Graduate Institute of Medical Education and Research, ChandigarhPhase 3
UnknownStudy to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light
NCT04741061
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationPhase 3
UnknownAn Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine
NCT04713488
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian FederationPhase 1 / Phase 2
UnknownClinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute R
NCT04640233
Dr. Reddy's Laboratories LimitedPhase 2 / Phase 3
CompletedA Study of Ad26.COV2.S in Adults (COVID-19)
NCT04436276
Janssen Vaccines & Prevention B.V.Phase 1 / Phase 2